Literature DB >> 31408613

CD82 controls CpG-dependent TLR9 signaling.

Nida S Khan1,2,3,4, Daniel P Lukason1, Marianela Feliu1, Rebecca A Ward1, Allison K Lord1, Jennifer L Reedy1,4, Zaida G Ramirez-Ortiz4,5,6, Jenny M Tam1, Pia V Kasperkovitz7, Paige E Negoro1, Tammy D Vyas1, Shuying Xu1, Melanie M Brinkmann8,9, Mridu Acharaya10,11, Katerina Artavanis-Tsakonas12, Eva-Maria Frickel13, Christine E Becker14, Zeina Dagher1, You-Me Kim15, Eicke Latz16,17,15, Hidde L Ploegh18, Michael K Mansour1,4, Cindy K Miranti19,20, Stuart M Levitz16, Jatin M Vyas1,4.   

Abstract

The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-κB nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.-Khan, N. S., Lukason, D. P., Feliu, M., Ward, R. A., Lord, A. K., Reedy, J. L., Ramirez-Ortiz, Z. G., Tam, J. M., Kasperkovitz, P. V., Negoro, P. E., Vyas, T. D., Xu, S., Brinkmann, M. M., Acharaya, M., Artavanis-Tsakonas, K., Frickel, E.-M., Becker, C. E., Dagher, Z., Kim, Y.-M., Latz, E., Ploegh, H. L., Mansour, M. K., Miranti, C. K., Levitz, S. M., Vyas, J. M. CD82 controls CpG-dependent TLR9 signaling.

Entities:  

Keywords:  TLRs; macrophages; myddosome; tetraspanins

Mesh:

Substances:

Year:  2019        PMID: 31408613      PMCID: PMC6988855          DOI: 10.1096/fj.201901547R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  69 in total

1.  Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells.

Authors:  H Shirota; K Sano; N Hirasawa; T Terui; K Ohuchi; T Hattori; K Shirato; G Tamura
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

2.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

Authors:  Eicke Latz; Anjali Verma; Alberto Visintin; Mei Gong; Cherilyn M Sirois; Dionne C G Klein; Brian G Monks; C James McKnight; Marc S Lamphier; W Paul Duprex; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2007-06-17       Impact factor: 25.606

3.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

Authors:  Koichi Tabeta; Kasper Hoebe; Edith M Janssen; Xin Du; Philippe Georgel; Karine Crozat; Suzanne Mudd; Navjiwan Mann; Sosathya Sovath; Jason Goode; Louis Shamel; Anat A Herskovits; Daniel A Portnoy; Michael Cooke; Lisa M Tarantino; Tim Wiltshire; Benjamin E Steinberg; Sergio Grinstein; Bruce Beutler
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

4.  Role of VAMP3 and VAMP7 in the commitment of Yersinia pseudotuberculosis to LC3-associated pathways involving single- or double-membrane vacuoles.

Authors:  Laure-Anne Ligeon; Kevin Moreau; Nicolas Barois; Antonino Bongiovanni; Delphine-Armelle Lacorre; Elisabeth Werkmeister; Véronique Proux-Gillardeaux; Thierry Galli; Frank Lafont
Journal:  Autophagy       Date:  2014-07-10       Impact factor: 16.016

5.  Dectin-1 interaction with tetraspanin CD37 inhibits IL-6 production.

Authors:  Friederike Meyer-Wentrup; Carl G Figdor; Marleen Ansems; Peter Brossart; Mark D Wright; Gosse J Adema; Annemiek B van Spriel
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock.

Authors:  T Sparwasser; T Miethke; G Lipford; A Erdmann; H Häcker; K Heeg; H Wagner
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

Review 7.  SMOCs: supramolecular organizing centres that control innate immunity.

Authors:  Jonathan C Kagan; Venkat Giri Magupalli; Hao Wu
Journal:  Nat Rev Immunol       Date:  2014-10-31       Impact factor: 53.106

8.  Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.

Authors:  Martijn H M G M den Brok; Roger P M Sutmuller; Stefan Nierkens; Erik J Bennink; Liza W J Toonen; Carl G Figdor; Theo J M Ruers; Gosse J Adema
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

9.  Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation.

Authors:  Mayumi Suzuki; Isao Tachibana; Yoshito Takeda; Ping He; Seigo Minami; Takeo Iwasaki; Hiroshi Kida; Sho Goya; Takashi Kijima; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Ichiro Kawase
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  CD82/KAI1 Maintains the Dormancy of Long-Term Hematopoietic Stem Cells through Interaction with DARC-Expressing Macrophages.

Authors:  Jin Hur; Jae-Il Choi; Hwan Lee; Pniel Nham; Tae-Won Kim; Cheong-Whan Chae; Ji-Yeon Yun; Jin-A Kang; Jeehoon Kang; Sang Eun Lee; Chang-Hwan Yoon; Kyungjin Boo; Seokjin Ham; Tae-Young Roh; Jong Kwan Jun; Ho Lee; Sung Hee Baek; Hyo-Soo Kim
Journal:  Cell Stem Cell       Date:  2016-03-17       Impact factor: 25.269

View more
  4 in total

1.  Tetraspanin CD82 restrains phagocyte migration but supports macrophage activation.

Authors:  Erin N S McGowan; Osanna Wong; Eleanor Jones; Julie Nguyen; Janet Wee; Maria C Demaria; Devy Deliyanti; Chad J Johnson; Michael J Hickey; Malcolm J McConville; Jennifer L Wilkinson-Berka; Mark D Wright; Katrina J Binger
Journal:  iScience       Date:  2022-06-03

Review 2.  Tetraspanins in the regulation of mast cell function.

Authors:  Zane Orinska; Philipp M Hagemann; Ivana Halova; Petr Draber
Journal:  Med Microbiol Immunol       Date:  2020-06-07       Impact factor: 3.402

Review 3.  Role of Metastasis Suppressor KAI1/CD82 in Different Cancers.

Authors:  Wei Yan; Jinny Huang; Qian Zhang; Jian Zhang
Journal:  J Oncol       Date:  2021-07-09       Impact factor: 4.375

Review 4.  Regulation of the nucleic acid-sensing Toll-like receptors.

Authors:  Nicholas A Lind; Victoria E Rael; Kathleen Pestal; Bo Liu; Gregory M Barton
Journal:  Nat Rev Immunol       Date:  2021-07-16       Impact factor: 108.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.